117 results
8-K
BXRXQ
Baudax Bio, Inc.
12 Dec 23
Other Events
9:52pm
stock, could further depress the trading price of our common stock, and could have a long-term adverse impact on our ability to raise capital
424B3
BXRXQ
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
liabilities:
Accounts payable
Accrued expenses and other current liabilities
Current portion of long-term debt, net
Current portion of operating lease … operation
Total current liabilities
Long-term debt, net
Long-term operating lease liability
Deferred tax liability
Other long-term liabilities
Non-current
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
was the best alternative reasonably available to the Company to maximize shareholder value and position the Company for long-term success.
| Notice … from Phase 3 studies (e.g. long-term extension data); and may require one or more Phase 4 post-market studies and surveillance to further assess
DEFA14A
iay4gbz gr23xzhee6
21 Aug 23
Additional proxy soliciting materials
8:05am
8-K
EX-10.1
mhaodn
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
424B5
c6n 6ltkl53
18 Aug 23
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
zqh6kluu0nv eye
16 Aug 23
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
8:11am
DEFA14A
EX-99.1
pq4cskm
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.1
i6eab
9 Aug 23
Other Events
5:27pm
8-K
EX-99.1
dlug669cm8cj0 34u
28 Jun 23
Other Events
4:31pm
8-K
EX-99.1
gak22vrcwuu48
12 May 23
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
8:16am
424B3
5moi0qpnfl8lgmjs9hi
28 Apr 23
Prospectus supplement
4:02pm